aTyr Pharma, Inc. (ATYR) vs IGC Pharma, Inc. (IGC)
aTyr Pharma, Inc. and IGC Pharma, Inc. are both Biotechnology companies. aTyr Pharma, Inc. and IGC Pharma, Inc. are of similar size ($31.4M and $29.1M). aTyr Pharma, Inc. grew revenue faster over the last twelve months: 6.78% against −13.4%. aTyr Pharma, Inc. has the higher net margin (0.00% vs −795.5%) and the higher return on invested capital (0.00% vs −91.5%). Across the 18 metrics below, aTyr Pharma, Inc. leads on 13 and IGC Pharma, Inc. on 5.
Valuation
Profitability
| Metric | ATYR | IGC | Biotechnology median |
|---|---|---|---|
| Gross margin | 1.72% | 32.33% | 65.16% |
| Operating margin | 0.00% | (912.44%) | 0.00% |
| Net margin | 0.00% | (795.46%) | 0.00% |
| Free cash flow margin | 0.00% | (516.53%) | 0.00% |
| Return on equity | (98.67%) | (143.46%) | (57.72%) |
| Return on assets | (70.97%) | (100.44%) | (49.22%) |
| Return on invested capital | 0.00% | (91.53%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack